{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:00Z","timestamp":1786119420760,"version":"build-2736575974"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/gco.0b013e3283384911","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T09:17:51Z","timestamp":1272532671000},"page":"193-201","source":"Crossref","is-referenced-by-count":86,"title":["The role of anti-M\u00fcllerian hormone assessment in assisted reproductive technology outcome"],"prefix":"10.1097","volume":"22","author":[{"given":"Simone L","family":"Broer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BenWillem","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"D\u00f3lleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank JM","family":"Broekmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"R2-5-20210129","first-page":"271","article-title":"Research on the sexual differentiation of embryonic rabbit","volume":"36","author":"Jost","year":"1947","journal-title":"Arch Anat Microsc Morphol Exp"},{"key":"R3-5-20210129","first-page":"1","article-title":"Antimullerian hormone: the Jost factor","volume":"48","author":"Josso","year":"1993","journal-title":"Rec Prog Horm Res"},{"key":"R4-5-20210129","first-page":"3836","article-title":"Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1242\/dev.113.2.613","article-title":"Expression of the mouse antimullerian hormone gene suggests a role in both male and female sexual differentiation","volume":"113","author":"Munsterberg","year":"1991","journal-title":"Development"},{"key":"R6-5-20210129","first-page":"152","article-title":"Mullerian inhibiting substance: a gonadal hormone with multiple functions","volume":"14","author":"Lee","year":"1993","journal-title":"Endocr Rev"},{"issue":"1\u20132","key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2004.09.008","article-title":"Anti-Mullerian hormone and folliculogenesis","volume":"234","author":"Visser","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/en.2005-1588","article-title":"Serum antimullerian hormone levels reflect the size of the primordial follicle pool in mice","volume":"147","author":"Kevenaar","year":"2006","journal-title":"Endocrinology"},{"key":"R9-5-20210129","first-page":"200","article-title":"Initial and cyclic recruitment of ovarian follicles","volume":"21","author":"McGee","year":"2000","journal-title":"Endocr Rev"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/rep.0.1240601","article-title":"Regulation of ovarian function: the role of anti-Mullerian hormone","volume":"124","author":"Durlinger","year":"2002","journal-title":"Reproduction"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Antimullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/endo-125-2-1060","article-title":"Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle","volume":"125","author":"Ueno","year":"1989","journal-title":"Endocrinology"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1095\/biolreprod50.6.1238","article-title":"Mullerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection","volume":"50","author":"Hirobe","year":"1994","journal-title":"Biol Reprod"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1210\/jc.2006-1079","article-title":"Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life","volume":"91","author":"Bergada","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2003.09.011","article-title":"Anti-Mullerian hormone levels in serum from human foetuses and children: pattern and clinical interest","volume":"211","author":"Guibourdenche","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil Steril"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Anti-Mullerian hormone serum levels: a putative marker for ovarian aging.","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Antimullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Antimullerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.2007-2093","article-title":"Relationship of serum anti-Mullerian hormone concentration to age of menopause","volume":"93","author":"van Disseldorp","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","article-title":"Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women","volume":"22","author":"Tsepelidis","year":"2007","journal-title":"Hum Reprod"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fertnstert.2007.04.054","article-title":"Statistically significant changes of antimullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women","volume":"89","author":"Wunder","year":"2008","journal-title":"Fertil Steril"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/humrep\/dem258","article-title":"Serum antimullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills","volume":"22","author":"Arbo","year":"2007","journal-title":"Hum Reprod"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.fertnstert.2006.03.047","article-title":"Antimullerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate","volume":"86","author":"Mohamed","year":"2006","journal-title":"Fertil Steril"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/humrep\/deh819","article-title":"Anti-Mullerian hormone concentrations in maternal serum during pregnancy.","volume":"20","author":"La Marca","year":"2005","journal-title":"Hum Reprod"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/humrep\/deg043","article-title":"Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/humrep\/dep035","article-title":"Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE - ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE).","volume":"24","author":"Nyboe","year":"2009","journal-title":"Hum Reprod"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(96)05291-9","article-title":"Factors that affect outcome of in-vitro fertilisation treatment","volume":"348","author":"Templeton","year":"1996","journal-title":"Lancet"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.fertnstert.2006.02.129","article-title":"Declining estimates of infertility in the United States: 1982\u20132002","volume":"86","author":"Stephen","year":"2006","journal-title":"Fertil Steril"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1136\/bmj.302.6789.1361","article-title":"Delaying childbearing: effect of age on fecundity and outcome of pregnancy","volume":"302","author":"Noord-Zaadstra","year":"1991","journal-title":"BMJ"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","article-title":"The variability of female reproductive ageing","volume":"8","author":"te Velde","year":"2002","journal-title":"Hum Reprod Update"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/oxfordjournals.aje.a009609","article-title":"International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"148","author":"Morabia","year":"1998","journal-title":"Am J Epidemiol"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1353\/hub.2001.0029","article-title":"International variability of ages at menarche and menopause: patterns and main determinants","volume":"73","author":"Thomas","year":"2001","journal-title":"Hum Biol"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1009465324197","article-title":"Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet","volume":"17","author":"Fasouliotis","year":"2000","journal-title":"J Assist Reprod Genet"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deg472","article-title":"A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a \u2018standard\u2019 dose of 150 IU\/day in 'standard\u2019 patients undergoing IVF\/ICSI treatment","volume":"18","author":"Popovic-Todorovic","year":"2003","journal-title":"Hum Reprod"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/humrep\/dem285","article-title":"The ISMAAR proposal on terminology for ovarian stimulation for IVF","volume":"22","author":"Nargund","year":"2007","journal-title":"Hum Reprod"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1472-6483(10)60633-5","article-title":"Optimum number of oocytes for a successful first IVF treatment cycle","volume":"13","author":"van der Gaast","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in healthcare: systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(05)66422-7","article-title":"Refining clinical diagnosis with likelihood ratios","volume":"365","author":"Grimes","year":"2005","journal-title":"Lancet"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/humrep\/del042","article-title":"Value of ovarian reserve testing before IVF: a clinical decision analysis","volume":"21","author":"Mol","year":"2006","journal-title":"Hum Reprod"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/humrep\/17.6.1519","article-title":"Young age does not protect against the adverse effects of reduced ovarian reserve: an eight year study","volume":"17","author":"El Toukhy","year":"2002","journal-title":"Hum Reprod"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1472-6483(10)62164-5","article-title":"Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles","volume":"6","author":"Ulug","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"R50-5-20210129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R52-5-20210129","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"R53-5-20210129","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2008.08.002","article-title":"Anti-Mullerian hormone and ovarian dysfunction","volume":"19","author":"Broekmans","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"R54-5-20210129","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"R55-5-20210129","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-0528.2005.00670.x","article-title":"Antral follicle count, antimullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?","volume":"112","author":"Muttukrishna","year":"2005","journal-title":"BJOG"},{"key":"R56-5-20210129","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.2004.00452.x","article-title":"Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF\/ICSI patients?","volume":"111","author":"Muttukrishna","year":"2004","journal-title":"BJOG"},{"key":"R57-5-20210129","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist\u2013gonadotropin treatment","volume":"20","author":"Penarrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"R58-5-20210129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1479-828X.2005.00332.x","article-title":"Antimullerian hormone as a marker of ovarian reserve","volume":"45","author":"Tremellen","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R59-5-20210129","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"R60-5-20210129","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/humrep\/del435","article-title":"Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population","volume":"22","author":"McIlveen","year":"2007","journal-title":"Hum Reprod"},{"key":"R61-5-20210129","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antimullerian hormone as an indicator of ovarian reserve","volume":"85","author":"Ficicioglu","year":"2006","journal-title":"Fertil Steril"},{"key":"R62-5-20210129","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/humrep\/del421","article-title":"Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology","volume":"22","author":"La Marca","year":"2007","journal-title":"Hum Reprod"},{"key":"R63-5-20210129","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/del127","article-title":"Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles","volume":"21","author":"Ebner","year":"2006","journal-title":"Hum Reprod"},{"key":"R64-5-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","article-title":"Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection","volume":"87","author":"Smeenk","year":"2007","journal-title":"Fertil Steril"},{"issue":"1\u20132","key":"R65-5-20210129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2006.06.013","article-title":"Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART)","volume":"375","author":"Freour","year":"2007","journal-title":"Clin Chim Acta"},{"key":"R66-5-20210129","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.fertnstert.2007.07.1293","article-title":"Evaluation of AMH as test for the prediction of ovarian reserve.","volume":"90","author":"Kwee","year":"2008","journal-title":"Fertil Steril"},{"key":"R67-5-20210129","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles: implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"R68-5-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1472-6483(10)60892-9","article-title":"Mullerian inhibiting substance is an accurate marker of ovarian response in women of advanced reproductive age undergoing IVF","volume":"14","author":"Nakhuda","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"R69-5-20210129","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","article-title":"Anti-Mullerian hormone as a predictor of IVF outcome","volume":"14","author":"Lekamge","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"R70-5-20210129","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.fertnstert.2007.05.040","article-title":"Anti-Mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients","volume":"89","author":"Elgindy","year":"2008","journal-title":"Fertil Steril"},{"key":"R71-5-20210129","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/den108","article-title":"Relevance of anti-Mullerian hormone measurement in a routine IVF program","volume":"23","author":"Gnoth","year":"2008","journal-title":"Hum Reprod"},{"key":"R72-5-20210129","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajog.2008.05.004","article-title":"Assessment of ovarian reserve with anti-Mullerian hormone: a comparison of the predictive value of anti-Mullerian hormone, follicle-stimulating hormone, inhibin B, and age","volume":"199","author":"Riggs","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R73-5-20210129","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.fertnstert.2008.10.042","article-title":"A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.","volume":"93","author":"Jayaprakasan","year":"2010","journal-title":"Fertil Steril"},{"key":"R74-5-20210129","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil Steril"},{"issue":"4 Suppl","key":"R75-5-20210129","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.fertnstert.2008.09.069","article-title":"Comparing anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function","volume":"91","author":"Barad","year":"2009","journal-title":"Fertil Steril"},{"key":"R76-5-20210129","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","article-title":"Serum antimullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee","year":"2008","journal-title":"Hum Reprod"},{"key":"R77-5-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10815-009-9319-5","article-title":"Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mullerian hormone versus small antral follicle count (2-6 mm)","volume":"26","author":"Aflatoonian","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"R79-5-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev"},{"key":"R80-5-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmm034","article-title":"Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation","volume":"14","author":"Fauser","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R81-5-20210129","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.fertnstert.2005.10.052","article-title":"Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization","volume":"85","author":"Nakhuda","year":"2006","journal-title":"Fertil Steril"},{"key":"R82-5-20210129","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.fertnstert.2007.10.078","article-title":"Anti-Mullerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization\/intracytoplasmic sperm injection","volume":"90","author":"Wunder","year":"2008","journal-title":"Fertil Steril"},{"key":"R83-5-20210129","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10815-009-9332-8","article-title":"Serum anti-Mullerian hormone predicts ovarian response and cycle outcome in IVF patients","volume":"26","author":"Wu","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"R84-5-20210129","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/jc.2006-1053","article-title":"Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization","volume":"92","author":"Fanchin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R85-5-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1472-6483(10)60323-9","article-title":"Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool","volume":"17","author":"Hendriks","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"R86-5-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humrep\/dei270","article-title":"Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology","volume":"21","author":"Silberstein","year":"2006","journal-title":"Hum Reprod"},{"key":"R87-5-20210129","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","article-title":"Anti-Mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?","volume":"16","author":"Lie Fong","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"R88-5-20210129","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/humrep\/14.4.964","article-title":"Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?","volume":"14","author":"Lashen","year":"1999","journal-title":"Hum Reprod"},{"key":"R89-5-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/humupd\/dmn053","article-title":"The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis","volume":"15","author":"Verberg","year":"2009","journal-title":"Hum Reprod Update"},{"key":"R90-5-20210129","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.fertnstert.2007.12.077","article-title":"How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.","volume":"91","author":"Kyrou","year":"2009","journal-title":"Fertil Steril"},{"key":"R92-5-20210129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10815-008-9266-6","article-title":"Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve","volume":"25","author":"Lekamge","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"R93-5-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1472-6483(10)60256-8","article-title":"Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study","volume":"18","author":"Olivennes","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"R94-5-20210129","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GCO.0b013e3283384911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:16:00Z","timestamp":1786040160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-201006000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e3283384911","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}